Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease.


Journal

The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 29 03 2021
accepted: 13 09 2021
pubmed: 4 11 2021
medline: 22 2 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

A multicenter adult inflammatory bowel disease learning health system (IBD Qorus) implemented clinical care process changes for reducing unplanned emergency department visits and hospitalizations using a Breakthrough Series Collaborative approach. Using Markov decision models, we determined the health economic impact of participating in the Collaborative from the third-party payer perspective. Across all 23 sites, participation in the Collaborative was associated with lower annual costs by an average of $2,528 ± $233 per patient when compared with the baseline period. Implementing clinical care process changes using a Collaborative approach was associated with overall cost savings. Future work should examine which specific interventions are most effective and whether such cost savings are sustainable.

Identifiants

pubmed: 34730561
doi: 10.14309/ajg.0000000000001540
pii: 00000434-202112000-00027
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2459-2464

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK117058
Pays : United States
Organisme : NIDDK NIH HHS
ID : R03 DK129631
Pays : United States

Informations de copyright

Copyright © 2021 by The American College of Gastroenterology.

Références

Bounthavong M, Li M, Watanabe JH. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Soc Adm Pharm 2017;13(3):530–8.
Gunnarsson C, Chen J, Rizzo JA, et al. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: Evidence from a US national survey. Dig Dis Sci 2012;57(12):3080–91.
Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 2019;156(1):254–72.
Dieleman JL, Cao J, Chapin A, et al. US health care spending by payer and health condition, 1996-2016. JAMA 2020;323(9):863–84.
Ma C, Smith MK, Guizzetti L, et al. Assessing national trends and disparities in ambulatory, emergency department, and inpatient visits for inflammatory bowel disease in the United States (2005-2016). Clin Gastroenterol Hepatol 2020;18(11):2500–9.e1.
Johnson LC, Melmed GY, Nelson EC, et al. Fostering collaboration through creation of an IBD learning health system. Am J Gastroenterol 2017;112(3):406–8.
Melmed G, Brant O, Hou J, et al. Quality of care initiative improves outcomes for patients with inflammatory bowel disease. Am J Gastroenterol 2021;116(12): This issue.
Kim AH, Roberts C, Feagan BG, et al. Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus. J Crohns Colitis 2018;12(4):408–18.
van Deen WK, Freundlich N, Kown MH, et al. The Reliability of Patient Self-reported Utilization in an Inflammatory Bowel Diseases Learning Health System. Crohn's Colitis 360 2021;3:1–6.
Regueiro M, Click B, Anderson A, et al. Reduced unplanned care and disease activity and increased quality of life after patient enrollment in an inflammatory bowel disease medical home. Clin Gastroenterol Hepatol 2018;16(11):1777–85.
Beard JA, Franco DL, Click BH. The burden of cost in inflammatory bowel disease: A medical economic perspective and the future of value-based care. Curr Gastroenterol Rep 2020;22(2):6.
Del Hoyo J, Nos P, Faubel R, et al. A web-based telemanagement system for improving disease activity and quality of life in patients with complex inflammatory bowel disease: Pilot randomized controlled trial. J Med Internet Res 2018;20(11):e11602.

Auteurs

Christopher V Almario (CV)

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, California, USA.

Lawrence Kogan (L)

Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Welmoed K van Deen (WK)

Erasmus School of Health Policy and Management, Division of Health Technology Assessment, Erasmus University Rotterdam, Rotterdam, the Netherlands.

Frank I Scott (FI)

Division of Gastroenterology and Hepatology, University of Colorado, Aurora, Colorado, USA.

Siddharth Singh (S)

Division of Gastroenterology, University of California at San Diego, San Diego, California, USA.

Jason K Hou (JK)

Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.

Donald Lum (D)

The Oregon Clinic, Portland, Oregon, USA.

Humberto Aguilar (H)

Gastrointestinal Specialists, Shreveport, Louisiana, USA.

John Betteridge (J)

Regional GI, Lancaster, Pennsylvania, USA.

Ann Flynn (A)

Division of Gastroenterology, Hepatology, & Nutrition, University of Utah, Salt Lake City, Utah, USA.

Mark Gerich (M)

Division of Gastroenterology and Hepatology, University of Colorado, Aurora, Colorado, USA.

Lia Kaufman (L)

Spectrum Health, Grand Rapids, Michigan, USA.

Mark C Mattar (MC)

Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.

Carrie Mize (C)

Gastro One, Germantown, Tennessee, USA.

Arthur Ostrov (A)

Saratoga-Schenectady Gastroenterology Associates, Saratoga, New York, USA.

Samir A Shah (SA)

Gastroenterology Associates, Providence, Rhode Island, USA.

Ziad Younes (Z)

Gastro One, Germantown, Tennessee, USA.

S Alandra Weaver (SA)

Crohn's & Colitis Foundation, New York, New York, USA.

Caren Heller (C)

Crohn's & Colitis Foundation, New York, New York, USA.

Corey A Siegel (CA)

Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Gil Y Melmed (GY)

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH